Jon Congleton
2017 - Nivalis Therapeutics
In 2017, Jon Congleton earned a total compensation of $739.6K as Former President and Chief Executive Officer at Nivalis Therapeutics, a 64% decrease compared to previous year.
Compensation breakdown
| Salary | $18,750 |
|---|---|
| Other | $720,896 |
| Total | $739,646 |
Congleton received $720.9K in other compensation, accounting for 97% of the total pay in 2017.
Congleton also received $18.8K in salary.
Rankings
In 2017, Jon Congleton's compensation ranked 10,361st out of 14,666 executives tracked by ExecPay. In other words, Congleton earned more than 29.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,361 out of 14,666 | 29th |
Division Manufacturing | 4,017 out of 5,772 | 30th |
Major group Chemicals And Allied Products | 1,419 out of 2,075 | 32nd |
Industry group Drugs | 1,155 out of 1,731 | 33rd |
Industry Pharmaceutical Preparations | 903 out of 1,333 | 32nd |
Source: SEC filing on April 24, 2018.
Congleton's colleagues
We found five more compensation records of executives who worked with Jon Congleton at Nivalis Therapeutics in 2017.
2017
Mitchell Gold
Nivalis Therapeutics
Chief Executive Officer
2017
Janice Troha
Nivalis Therapeutics
Chief Operating Officer
2017
R Carruthers
Nivalis Therapeutics
Chief Financial Officer
2017
Stanford Peng
Nivalis Therapeutics
Chief Medical Officer
2017
Paul Rickey
Nivalis Therapeutics